OKYO Pharma Limited (OKYO)
NASDAQ·Healthcare·Biotechnology
$1.40
-2.45%
Mkt Cap $69.35M
Analyst Ratings
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+258.4%
Consensus $5.00 vs current $1.40
NASDAQ·Healthcare·Biotechnology
$1.40
-2.45%
Mkt Cap $69.35M
No recent rating data.
Price Target (2 analysts)
$5.00
Range $5.00 – $5.00
+258.4%
Consensus $5.00 vs current $1.40